EUVIMED · CrossrefZeitschrift
Arthritis & Rheumatology
ISSN 2326-5191 · Wiley
Neueste Artikel
Initial Treatment Strategies and Outcomes Across Hemodynamic Thresholds and Risk Stratification in Incident Systemic Sclerosis–Associated Pulmonary Arterial Hypertension: A EUSTAR Analysis
Durable and Additive Disease Control at 52 Weeks With Ixekizumab Plus Tirzepatide Versus Ixekizumab Alone in Adults With Psoriatic Arthritis and Obesity or Overweight: Additional Results From a Randomized Clinical Trial
Cluster analysis identifies anti‐synthetase syndrome as a distinct and heterogeneous clinical entity: Analysis from the Classification Criteria for Anti‐Synthetase Syndrome project database
Differentiation and Pathologic Significance of Tissue‐Resident Memory‐Like CD8 + T Cells in Systemic Lupus Erythematosus
Ulcerated Gottron's papules in anti‐MDA5 dermatomyositis
Winner of the 2026 American College of Rheumatology Annual Image Competition
Predicting Inactive Disease in Juvenile Idiopathic Arthritis: A Dynamic Machine Learning Approach
Synovial Tissue‐Guided Interleukin‐17A Inhibition for Refractory Arthritis in a Patient With Systemic Juvenile Idiopathic Arthritis
Comparative Risks of Mortality and Fractures in Patients With Osteoarthritis Initiating Tramadol Versus Other Opioids
Effects of a Smartphone‐Enabled, Physician‐Supervised Treat‐to‐Target Model for Gout Management: A 12‐Month Randomized Controlled Trial
Spatial Proteomics Identifies Distinct Synovial Microenvironments in Hip and Knee Osteoarthritis
The Booster dilemma: Balancing COVID ‐19 protection and vaccine fatigue in the rheumatology population.
Clinical Image: B‐cell lymphoma mimicking myositis
MDL ‐800–Induced Sirtuin 6 Activation Decreases Age‐Associated Osteoarthritis in Mice
Clinical Images: Characteristic nail and skeletal findings in nail–patella syndrome
Skin Transcriptomics Reveal Shared Molecular Mechanisms for Skin and Lung Involvement in Systemic Sclerosis
Glucagon‐Like Peptide‐1 Receptor Agonist Therapy Is Associated With Improvement in Psoriatic Arthritis–Related and Metabolic Outcomes: A Retrospective Analysis of Two Cohorts
Effects of Metabolic Dysregulation on Macrophage Polarization in Rheumatoid Arthritis
Abstract Supplement ACR Convergence 2026
Can Ultrasound Guide Treatment Decisions in Difficult‐to‐Treat Rheumatoid Arthritis?
Sustained Inhibition of Structural Damage Progression and Improvements in Disease Activity With Guselkumab in Biologic‐Naïve Participants with Active and Erosive Psoriatic Arthritis: Results Through Week 48 of the Phase 3b Randomized, Double‐Blind, Placebo‐Controlled APEX Study
Genetic and Population Analyses Implicate Thyroid‐Related Regulation of RNF144B in Chondrocalcinosis
Dual‐Targeting BCMA – CD19 CAR ‐T Cell Therapy in Systemic Lupus Erythematosus: Single‐Cell and Immune Repertoire Analysis Reveals Mechanisms of Immune Reconstitution
Association of Clonal Hematopoiesis With Incident, Late‐Onset, Seropositive Rheumatoid Arthritis
Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial
Hepatotoxicity of Avacopan: Real‐World Incidence and Confirmed Cases of Severe Drug‐Induced Liver Injury in a US National Rheumatology Registry
Tissue Damage in Rheumatoid Arthritis Is Genetically Linked to Low Peptidylglycine Alpha‐Amidating Monooxygenase Activity in Synovial Fibroblasts
Expert Perspective: Low Dose Radiation Therapy and Osteoarthritis Pain
Nationwide Temporal Trends in Adverse Pregnancy Outcomes and Treatments in Systemic Lupus Erythematosus Pregnancy Over Two Decades in Sweden
Efficacy and Safety of Guselkumab in Participants With Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week‐24 Results of a Phase 3, Randomized, Placebo‐Controlled Study
EUVIMED